10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Increased cortisol levels in hair of recent Ecstasy/MDMA users.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Previous research has revealed an acute 8-fold increase in salivary cortisol following self-administrated Ecstasy/MDMA in dance clubbers. It is currently not known to what extent repeated usage impacts upon activity of the hypothalamic-pituitary-adrenal axis over a more prolonged period of time. This study investigated the integrated cortisol levels in 3-month hair samples from recent Ecstasy/MDMA users and non-user controls. One hundred and one unpaid participants (53 males, 48 females; mean age 21.75 years) completed the University of East London recreational drug use questionnaire, modified to cover the past 3-months of usage. They comprised 32 light recent Ecstasy/MDMA users (1-4 times in last 3 months), 23 recent heavy MDMA users (+5 times in last 3 months), and 54 non-user controls. Volunteers provided 3 cm hair samples for cortisol analysis. Hair cortisol levels were observed to be significantly higher in recent heavy MDMA users (mean = 55.0 ± 80.1 pg/mg), compared to recent light MDMA users (19.4 ± 16.0 pg/mg; p=0.015), and to non-users (13.8 ± 6.1 pg/mg; p<0.001). Hence the regular use of Ecstasy/MDMA was associated with almost 4-fold raised hair cortisol levels, in comparison with non-user controls. The present results are consistent with the bio-energetic stress model for Ecstasy/MDMA, which predicts that repeated stimulant drug use may increase cortisol production acutely, and result in greater deposits of the hormone in hair. These data may also help explain the neurocognitive, psychiatric, and other psychobiological problems of some abstinent users. Future study design and directions for research concerning the psychoneuroendocrinological impact of MDMA are also discussed.

          Related collections

          Author and article information

          Journal
          Eur Neuropsychopharmacol
          European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
          1873-7862
          0924-977X
          Mar 2014
          : 24
          : 3
          Affiliations
          [1 ] Department of Psychology, Swansea University, Swansea SA2 8PP, Wales, UK; Centre for Human Psychopharmacology (CHP), Swinburne University, Australia. Electronic address: a.c.parrott@swansea.ac.uk.
          [2 ] Department of Psychology, Swansea University, Swansea SA2 8PP, Wales, UK.
          [3 ] Psychophysiology and Stress Research Group, Westminster University, London, UK.
          [4 ] Department of Psychology, Swansea University, Swansea SA2 8PP, Wales, UK; Centre for Human Psychopharmacology (CHP), Swinburne University, Australia.
          [5 ] Department of Psychology, Technical University of Dresden, Dresden, Germany.
          Article
          S0924-977X(13)00337-4
          10.1016/j.euroneuro.2013.11.006
          24333019
          66f54e7e-ed54-4ab6-9d69-6a7c51428255
          © 2013 Published by Elsevier B.V. and ECNP.
          History

          Cortisol,Ecstasy,HPA axis,MDMA,Neurohormone,Stress
          Cortisol, Ecstasy, HPA axis, MDMA, Neurohormone, Stress

          Comments

          Comment on this article